All these findings on PD-L1 and sPD-L1 are in accordance with our study: overexpression of sPD-L1 seems to characterize the more aggressive pancreatic tumors, as observed in our metastatic and relapsed patients. Here, CD274 is linked to pancreatic neoplasm.